Davangere Sugar Company Limited (BOM:543267)
3.420
-0.070 (-2.01%)
At close: Jul 28, 2025
Verve Therapeutics Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Source: S&P Global Market Intelligence. Standard template. Financial Sources.